AlphaGenome is a leap forward in the ability to study the human blueprint. But the fine workings of our DNA are still largely ...

Silicon Valley and Wall Street are pouring billions into AI drug discovery in a high-stakes bet to “solve” disease.

Apple plans to revamp Siri later this year by turning the ‍digital assistant into the company’s first artificial intelligence ...

The former House Speaker's equity portfolio reveals two stocks she's targeted.

The data centre construction boom has also prompted major players, including Meta Platforms Read more at The Business Times.

Colin is an Associate Editor focused on tech and financial news. He has more than three years of experience editing, proofreading, and fact-checking content on current financial events and politics.

Alphabet (GOOG) (GOOGL) appears likely to record a fresh uplift to the value of one of its largest private holdings after SpaceX (SPACE) completed a new tender offer that effectively prices the ...

Alphabet delivered record Q3-25 results, surpassing $100B in quarterly net revenue and posting 35% YoY earnings growth, driven by AI and cloud momentum. GOOG raised 2025 capex guidance to $91–93B, ...

Google's recently updated Gemini model outperformed rivals, setting off alarm bells at OpenAI. OpenAI CEO Sam Altman issued a "code red," shifting employee priorities to improving ChatGPT. Alphabet's ...

Whether you have buddies in the military or have watched a ton of war movies, you've probably heard several phrases that you didn't understand off the bat. There is a shorthand often used by the ...

EMBL researchers created SDR-seq, a next-generation tool that decodes both DNA and RNA from the same cell. It finally opens access to non-coding regions, where most disease-associated genetic variants ...